Fresh analysis indicates that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who end conventional lifestyle programs.
Published data in a leading medical journal points out that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"Users buying such treatments must be informed of the danger of fast rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.
That rate of regain implies a reversion to original weight in about one and a half years.
Analyzing Treatments
The research, which reviewed 37 of studies involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
The team emphasize that people who lose weight through diet and exercise generally have a slower weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Experts suggest the mechanism of the injections accounts for the accelerated regain.
These medications imitate a body's own chemical called GLP-1, which controls appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its own natural hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement results in hunger is uncontrolled, making overeating much more probable."
An Ongoing Disease?
Medical guidelines advise the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, considering the likelihood of weight regain, the therapy is often ongoing.
This opinion is reinforced by pharmaceutical companies, who note that the results "underscore the long-term character of obesity," akin to managing conditions like diabetes.
User Accounts
Users who have discontinued the medication explain a intense resurgence of appetite.
"It was like something that goes on and I was suddenly extremely hungry," said one woman.
The struggle is worsened if users have not developed sustainable lifestyle or habit changes during therapy.
Significant Use
Survey data suggest that millions of adults in the UK have tried these injections in the past year, with desire remaining high.
- Use is higher among women than males.
- The middle-aged age group shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
Finally, researchers caution that while the jabs are effective tools for shedding pounds, they are not a magic cure and long-term success likely depends on combined lifestyle support.
